| Tag | Content |
|---|
EnhancerAtlas ID | HS102-01886 |
Organism | Homo sapiens |
Tissue/cell | HuCCT1 |
Coordinate | chr1:161581660-161583460 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161582764-161582782 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161582760-161582778 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161582351-161582361 | GGGGCGGGGC | - | 6.02 | | ZNF263 | MA0528.1 | chr1:161582760-161582781 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 | | ZNF263 | MA0528.1 | chr1:161582205-161582226 | TGAGGAGTGCGGGGGGGAAGA | + | 6.2 |
|
| | Number of super-enhancer constituents: 14 | ID | Coordinate | Tissue/cell |
| SE_07357 | chr1:161580788-161584698 | Brain_Hippocampus_Middle_150 | | SE_09867 | chr1:161579384-161583530 | CD14 | | SE_12235 | chr1:161581303-161583400 | CD3 | | SE_12654 | chr1:161581792-161582273 | CD34_adult | | SE_12771 | chr1:161581912-161582301 | CD34_fetal | | SE_12771 | chr1:161582578-161582932 | CD34_fetal | | SE_13494 | chr1:161579645-161584358 | CD34_Primary_RO01536 | | SE_15335 | chr1:161579226-161584686 | CD4_Memory_Primary_7pool | | SE_16693 | chr1:161581295-161583416 | CD4_Naive_Primary_8pool | | SE_20036 | chr1:161580924-161584169 | CD56 | | SE_20740 | chr1:161577990-161584457 | CD8_Memory_7pool | | SE_22436 | chr1:161580812-161584433 | CD8_primiary | | SE_39938 | chr1:161580902-161584380 | K562 | | SE_53727 | chr1:161580858-161583334 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 161582451 | 161582780 | | chr1 | 161582212 | 161582506 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161611 | chr1 | 161580791 | 161583390 |
|
Enhancer Sequence | TCTTTCTCTA AGAATTCAAA CATAATTGCT GGTTGGTTCA AATCAGGAGG AAAAGTAAGG 60
ATGGAAAACA TACGTTGTCA AAAGTGGGAT TCGAACCCAC GCCTCCAGCG GAGGGTGCGA 120
TTTGAACGCA GCGCCTTAAG ACTGCTCGGC CATCCTGACA CACGTTTTGC TAAACTTCCT 180
AATTTCTCCT AATTTTATCA TATACTGATG GTGCACGCTA TCAGGTCACA TTAATGTGTC 240
TATTTACTGT TTCAAATAAA ATTGTAACTC TCTCTAGACC TTGTCGCAAA GCGGGAAAAA 300
TGAAACAGCC TCCGACAGCT CTTTCCTCTT TCCTCACTAC CCAAACTAAA CCTTAAGGCT 360
CCATTTTCCC TGGCGACTCT TCGAGCGCCC CTCTGCTTCT GTAGAGGGGT CGAGCCATGT 420
CAAGGTAGAC CCTGTGTCGG CCCGTCTCCC TCGGATCCTC CGCACCAATC ACTGTTGCTG 480
AATCCGACAC CCGGCGGATC CAGTGCGGAG TCTCGAACAG CTGCGGAGCT GGGAGCTACG 540
GGACATGAGG AGTGCGGGGG GGAAGAGAAG ACGGCGGAGG AAAATCCCCC GGCGGTGCTC 600
AACTGCGGCT TTCTCTCTCG GCTGTGAGCC GGCTCCGCCC TCCGGCTTCC AGAGCAAGTG 660
GCTTCTGCGT TCACCGCCCC CCGCCGTTTG TGGGGCGGGG CCGATTCATA AGAATCGGTT 720
CTCACCAATG GAGGGCTTAG CATGTTTAAC CTCAGGATCA TAAACAAAAG ACACTGCTAG 780
AACGGTCGGG AAAGTCATAC GCTTTGCTTA TCTTATATAT AGATTTCTAA AATTCCAAAC 840
CGGGGACGCG TTGGTGGTGT AGTGGTGAGC ACAGCTGCCT TTCAAGCAGT TAACGCGGGT 900
TCGATTCCCG GGTAACGAAA CGTTTTTGTC TTTCCTTCTA CGAAAAACTT TTCTGAGCCG 960
GAGCCTCCAG CGCGCTGTGT ATTCGTTTTA CGCCTCAACG AAACTGCAGC AATACCTCAC 1020
TTTCCGTACT CGCTTCCTGT CTTTCCCCTG GCCTCTTTCT AAACCCAGGC TTTTTTTGAA 1080
GGGATTAAAT TCTGATGGTT CTTTCCTCCC TTCCTTCCTT TGTAAACTTC CAACTCTTGA 1140
GGAATCTTTG GGATCATTTC AATCCTGGGA TGAGTCTTAG CTTCAGAAAG GGGCTCTTGT 1200
GTCTTCACTT GCGAGGTTCA TTCGCTAGCC TCTACAAATC ATCACTTAAG CCCCTAATTA 1260
TTCCCGGCCG AGGTCCTAGG CTAAGGTCCC GGGCCAAGCT TTCTAATTAG TCCCAGGCCA 1320
AGGTCCCAGG CCAACCTAAA TCACGCATTC TCCAAAACAG CCGGCAAACT AAGCACATTC 1380
CTTCCCGTTT CCAGTCCATA AACCCCCCCC CCCAAGTGGC CTCATAGTAA GCAACTCATT 1440
CGGGCCCCCT CTCTGCTGGC AAAAAGCTCA GATGTACTGG ACTGTGCATT TGATTTGGAA 1500
CTGAGTTACA TGGGAGAGAA GCAGGGATTC AGTTTGGCTG GGAATCAAAC TCTTTTGATA 1560
ATTTCCTAAT AAACTGATAG TCATTAGATG ACTTGTAGTC TCGATAAGTT GAAACTTTTT 1620
CCTAACATGC TGTTTATGAT ACTGAGTTCT TTGTCACCGG TTGAACTAAC AGCAATTGTA 1680
TTCACAAATT TTCCAGCCTT TAAAATACTG TCTGAGGGTT TTATGTATCC GTTATCTTTT 1740
ATTATACAAA AGTCATTTAT TGGAATGACA TATATAATTA GATTGACCCT AACCATTCAG 1800
|
